4articles
Targeting the gut microbiome with probiotics, prebiotics, and synbiotics offers a practical, low-risk protocol to support memory and global executive function in older adults.
Clinical evidence confirms targeted probiotic and synbiotic therapy lowers ALT, AST, and TNF-alpha while enhancing glycemic stability in metabolic liver dysfunction.
Combining targeted probiotic strains with plant polyphenols elevates short-chain fatty acids, enhances tryptophan conversion to protective indoles, and reduces gut permeability markers.
The species on the front of the box tells you almost nothing. Effects are documented at the strain level, and most products do not name theirs.